BIIB
Biogen·NASDAQ
--
--(--)
--
--(--)
BIIB fundamentals
Biogen (BIIB) released its earnings on Feb 6, 2026: revenue was 2.28B (YoY -7.16%), beat estimates; EPS was 1.99 (YoY -42.15%), beat estimates.
Revenue / YoY
2.28B
-7.16%
EPS / YoY
1.99
-42.15%
Report date
Feb 6, 2026
BIIB Earnings Call Summary for Q4,2025
- Growth Products Dominate: 2025 growth products ($3.3B) outpaced MS decline, with LEQEMBI ($134M Q4 sales), ZURZUVAE, and VUMERITY leading.
- Pipeline Momentum: 10 Phase III programs, including litifilimab (SLE), felzartamab (AMR), and BIIB080 (tau ASO), set to deliver data in 2026-2027.
- Strategic Acquisitions: Alcyone Therapeutics to enhance SPINRAZA delivery; $2.1B free cash flow supports R&D and launches.
- 2026 Outlook: Non-GAAP EPS $15.25-$16.25, revenue decline offset by growth products; lupus and nephrology launches key to future growth.
EPS
Revenue
Revenue & Expenses
BIIB has released its 2025 Q4 earnings report, with revenue of 2.28B, reflecting a YoY change of -7.14%, and net profit of -48.90M, showing a YoY change of -118.34%. The Sankey diagram below clearly presents BIIB's revenue sources and cost distribution.
Key Indicators
Biogen (BIIB) key financial stats and ratios, covering profitability, financial health, and leverage.
Biogen (BIIB)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biogen (BIIB)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biogen (BIIB)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biogen (BIIB) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biogen (BIIB) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What factors drove the changes in Biogen's revenue and profit?What is the market's earnings forecast for Biogen next quarter?What is Biogen's gross profit margin?Did Biogen beat or miss consensus estimates last quarter?What guidance did Biogen's management provide for the next earnings period?What does Biogen do and what are its main business segments?What were the key takeaways from Biogen's earnings call?What is the revenue and EPS growth rate for Biogen year over year?
